Precision for Medicine Expands in Asia-Pacific
Precision for Medicine, a significant player in the field of biomarker-driven clinical research and development, has made a notable move by opening a new office in Tokyo, Japan. This expansion signifies the company’s ongoing commitment to the Asia-Pacific region and emphasizes its role as a connector between local expertise and global development initiatives.
Japan holds a prominent position as the third-largest pharmaceutical market in the world, which comes with specific demands for locally generated clinical data during critical trials. Historically, these expectations have posed challenges for sponsors that aim to include Japan in their developmental strategies. However, with the establishment of the Tokyo office and the inclusion of senior leadership in Japan, Precision is well-equipped to ensure the delivery of high-quality services and consistency in global governance. The new office will also empower local personnel to adeptly navigate the regulatory, cultural, and operational intricacies that are essential for the successful execution of trials within the country.
James Cheong, Senior Vice President for the Asia-Pacific region at Precision, stated, “Japan is a vital component of global clinical development. By establishing our own office with dedicated leadership, we close the gap that previously existed between global trial designs and Japanese regulatory requirements. This offers our clients a consistent adherence to global standards supplemented by the assurance of a genuine local presence.”
The Tokyo office positions Precision to enhance collaboration with biopharmaceutical sponsors, investigators, crucial external experts, and various research sites. This shall not only facilitate a more agile operation but also foster stronger partnerships throughout Japan’s extensive research ecosystem.
Jing Ping Yeo, Vice President of Clinical Operations, shed light on the advantages of being physically present in Japan, punctuating that this enhances their ability to lead complex programs in oncology, autoimmune diseases, and rare diseases specifically tailored for Japanese patients. “This presence guarantees that Japanese scientific insights, emerging biomarker trends, and regulatory expectations are integrated into the global trial design from the very beginning—a critical factor, especially for specialized indications where localized expertise is indispensable,” explained Yeo.
The launch of the office in Japan is a strategic complement to Precision’s already extensive footprint in the Asia-Pacific, which includes more than 500 employees spread over other key locations such as Singapore, Mainland China, Hong Kong, India, South Korea, Taiwan, and Australia. Collectively, these offices offer a fully integrated, locally informed support system for clients looking to gain access to the global market.
Daisy DeWeese-Gatt, President of Clinical Solutions for Precision, shared her vision for the Asia-Pacific region, asserting that it should not merely serve as an addition but as an essential part of the ecosystem in developing and delivering global precision medicines. She emphasized, “The Japan office advances that vision and deepens our commitment to ensuring that innovative therapies reach those patients who require them most, while also ensuring representation of APAC populations in the process.”
About Precision for Medicine
Precision for Medicine stands at the forefront of biomarker-driven clinical research and development services, enabling life sciences companies to utilize biomarkers effectively in the precise targeting of patient treatments. Their transformational approach integrates clinical trial design with profound scientific knowledge, laboratory expertise, and advanced data intelligence, accelerating clinical development and approval processes. Operating under the Precision Medicine Group umbrella, Precision for Medicine employs approximately 3,500 professionals across more than 40 locations around the globe, providing unparalleled support to their clients in various regions.
For further information, visit
PrecisionForMedicine.com.